Leave Your Message

News

Novel Promoter Strategy Enhances Safety and Efficacy of CAR-T Therapy in Acute B Cell Leukemia

Novel Promoter Strategy Enhances Safety and Efficacy of CAR-T Therapy in Acute B Cell Leukemia

2024-07-25

Lu Daopei Hospital and Hebei Senlang Biotechnology have announced promising findings from their recent study on the safety and efficacy of CAR-T therapy for acute B cell leukemia. This collaboration highlights the potential of novel CAR-T cell designs to enhance patient outcomes.

view detail
Breakthrough Study Demonstrates Safety and Efficacy of CAR-T Therapy in Treating B-Cell Malignancies

Breakthrough Study Demonstrates Safety and Efficacy of CAR-T Therapy in Treating B-Cell Malignancies

2024-07-23

A new study led by Dr. Zhi-tao Ying from Peking University Cancer Hospital has demonstrated the safety and efficacy of IM19 CAR-T cell therapy in treating relapsed and refractory B-cell hematologic malignancies. Published in the Chinese Journal of New Drugs, the study reports that 11 out of 12 patients achieved complete remission with no severe adverse effects, showcasing the potential of IM19 as a promising treatment option for patients with limited alternatives.

view detail
Breakthrough Advances in Natural Killer (NK) Cells Over 50 Years

Breakthrough Advances in Natural Killer (NK) Cells Over 50 Years

2024-07-18

Over the past five decades, research on Natural Killer (NK) cells has revolutionized our understanding of innate immunity, offering promising new avenues for cancer and viral therapies.

view detail
New Insights on Mesenchymal Stem Cells and Their Potential in Treating Aging and Diseases

New Insights on Mesenchymal Stem Cells and Their Potential in Treating Aging and Diseases

2024-07-16

A recent special issue in the International Journal of Molecular Sciences highlights the role of mesenchymal stem cells (MSCs) and their derived products in combating aging and various diseases. This research underscores the potential of MSCs in regenerative medicine and addresses the challenges and opportunities in developing new therapeutic strategies.

view detail
Annual Clinical Blood Management and Transfusion Technology Training Held at Yanda Ludaopei Hospital

Annual Clinical Blood Management and Transfusion Technology Training Held at Yanda Ludaopei Hospital

2024-07-12

The 2024 Annual Training for Clinical Blood Management and Transfusion Technology in Sanhe City was successfully held at Yanda Ludaopei Hospital. This event aims to enhance clinical blood management and transfusion safety through comprehensive training sessions attended by over 100 healthcare professionals from various medical institutions.

view detail
Breakthrough in Pediatric Autoimmune Disease: CAR-T Cell Therapy Cures Lupus Patient

Breakthrough in Pediatric Autoimmune Disease: CAR-T Cell Therapy Cures Lupus Patient

2024-07-10

A pioneering study at Erlangen University Hospital successfully treated a 16-year-old girl with severe systemic lupus erythematosus (SLE) using CAR-T cell therapy. This marks the first use of this treatment for pediatric lupus, offering new hope for children with autoimmune diseases.

view detail
Enhancing the Effectiveness of PROTAC: A Groundbreaking Study

Enhancing the Effectiveness of PROTAC: A Groundbreaking Study

2024-07-04

A recent study in Nature Communications reveals key insights into the intrinsic signaling pathways that modulate the effectiveness of targeted protein degradation using PROTACs. This discovery could pave the way for more effective treatments for cancer and other diseases.

view detail
Promoting Health and Recovery: Daily Care for Leukemia Patients

Promoting Health and Recovery: Daily Care for Leukemia Patients

2024-07-03

Ensuring a safe and comfortable treatment experience for leukemia patients involves meticulous daily care, including environmental sanitation, personal hygiene, nutrition, and appropriate exercise. This guide provides essential tips for effective daily care to support recovery.

view detail
Stem Cell Safety Confirmed: Insights from The Lancet

Stem Cell Safety Confirmed: Insights from The Lancet

2024-06-28

A recent article in The Lancet's EClinical Medicine confirms the safety of mesenchymal stem cell (MSC) therapy, summarizing clinical trials from 2012 to 2019 and providing evidence of MSC's efficacy and low risk of adverse effects.

view detail
Comparative Study of ATG-T vs. ATLG in TBI-Based Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation

Comparative Study of ATG-T vs. ATLG in TBI-Based Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation

2024-06-25

A study by Dr. Lu Yue's team at Lu Daopei Hospital compared the use of ATG-T and ATLG in TBI-based conditioning regimens for alternative donor allogeneic hematopoietic stem cell transplantation (HSCT) in acute lymphoblastic leukemia (ALL) patients, highlighting significant findings in graft-versus-host disease (GVHD) prevention and viral infection rates.

view detail
NS7CAR-T Cell Therapy Shows Promise for Treating R/R T-ALL/LBL

NS7CAR-T Cell Therapy Shows Promise for Treating R/R T-ALL/LBL

2024-06-20

A recent study highlights the efficacy and safety of NS7CAR-T cell therapy in treating relapsed or refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) and T-cell lymphoblastic lymphoma (R/R T-LBL). This therapy offers new hope for patients with these aggressive forms of cancer.

view detail
Groundbreaking Results of CD7-Targeted CAR-T Therapy for T-ALL and T-LBL

Groundbreaking Results of CD7-Targeted CAR-T Therapy for T-ALL and T-LBL

2024-06-18

A recent study highlights the promising results of CD7-targeted chimeric antigen receptor (CAR) T cell therapy in treating patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).

view detail